Apollo Endosurgery Inc. (APEN)
NASDAQ: APEN
· Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM
Apollo Endosurgery Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 57M | 66.91M | 74.74M | 81.73M | 90.69M | 27.35M | 30.54M | 31.71M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.44M | 1.4M | 1.42M | 1.43M | 1.54M | 1.47M | 1.07M | 1.33M |
Receivables | 14.99M | 12.9M | 12.52M | 11.07M | 10.08M | 10.29M | 11.25M | 9.46M |
Inventory | 18.25M | 16.7M | 14.73M | 13.25M | 11.97M | 11.32M | 10.84M | 10.55M |
Other Current Assets | 2.64M | 2.27M | 2.44M | 2.45M | 1.97M | 4.95M | 4.4M | 4.17M |
Total Current Assets | 92.88M | 98.77M | 104.43M | 108.5M | 114.7M | 53.91M | 57.03M | 55.89M |
Property-Plant & Equipment | 7.51M | 7.2M | 5.92M | 5.77M | 5.59M | 5.59M | 5.82M | 5.85M |
Goodwill & Intangibles | 8.41M | 8.65M | 9M | 9.32M | 9.69M | 10.11M | 10.49M | 10.91M |
Total Long-Term Assets | 17.35M | 17.26M | 16.33M | 16.52M | 16.83M | 17.17M | 17.39M | 18.09M |
Total Assets | 110.23M | 116.03M | 120.76M | 125.02M | 131.53M | 71.08M | 74.42M | 73.98M |
Account Payables | 7.42M | 6.77M | 7.18M | 6.4M | 4.58M | 4.51M | 5.91M | 4.58M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 779K | n/a | n/a |
Short-Term Debt | 20.26M | 590K | 488K | 578K | 587K | 1.13M | n/a | 1.11M |
Other Current Liabilities | 11.86M | 9.11M | 8.72M | 6.98M | 9.31M | 9.25M | 8.53M | 6.91M |
Total Current Liabilities | 39.54M | 16.47M | 16.39M | 13.95M | 14.49M | 14.89M | 14.45M | 12.6M |
Long-Term Debt | 36.81M | 53.5M | 53.33M | 53.16M | 52.99M | 54.11M | 54.93M | 56.36M |
Other Long-Term Liabilities | 1.29M | 3.74M | 2.89M | 2.87M | 2.82M | 2.17M | 2.33M | 2.34M |
Total Long-Term Liabilities | 38.1M | 57.24M | 56.22M | 56.03M | 55.8M | 56.28M | 57.26M | 58.7M |
Total Liabilities | 77.64M | 73.72M | 72.61M | 69.98M | 70.29M | 71.17M | 71.7M | 71.29M |
Total Debt | 57.06M | 54.09M | 53.82M | 53.73M | 53.57M | 55.89M | 55.64M | 58.04M |
Common Stock | 42K | 42K | 41K | 40K | 40K | 30K | 29K | 27K |
Retained Earnings | -337.29M | -327.74M | -316.3M | -305.87M | -297.45M | -287.05M | -280.39M | -277.37M |
Comprehensive Income | 4.97M | 7.22M | 4.12M | 2.15M | 2.14M | 1.92M | 1.53M | 2.04M |
Shareholders Equity | 32.59M | 42.31M | 48.16M | 55.03M | 61.24M | -92K | 2.71M | 2.69M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |